SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVR: BULLS AND BEARS!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: frick who wrote (6021)5/15/1998 4:05:00 PM
From: JMood  Read Replies (2) of 8902
 
I don't like to move the conversation off the subject, but as someone has been hyping this stock on another board I follow (an internet stock) I feel I OK about asking a question separate from ADVR. I hold IFSC, which has FDA approval for genital warts and is looking for approval for HIV, and there is a lot of talk about off-label sales. That is, there is a theory proposed by some that within the AIDS community there is such a demand for a cure, that there is great potential for sales with or without FDA approval as long as you can get the drug. People point to Rogaine (first a heart disease drug under another name) and Phen-fen (sp?) as examples of a drug approved for one thing but eventually used for another purpose. The short of it is: does the off-label market have potential, and does ADVR have approval anywhere?

Thanks for any input.
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News